Lobbyists push to prevent Medicare fee reduction

Washington-While several major health issues that were sidetrackedby the Sept. 11 terrorist attacks are poised for consideration by Congresswhen it returns to action this month, lobbyists for urologists and otherphysician groups were working hard at press time to prevent a reductionin 2002 Medicare fees.

Related Content:

Drug Therapy

Pivotal data for lumasiran in PH1 published in NEJM

Nedosiran explored in primary hyperoxaluria type 3

Enrollment completed in pivotal trial of nedosiran for hyperoxaluria